One locus with prominent changes is BDNF, and in conjunction with the suggestion of BDNF as a potential target for design of new antidepressants, the epigenetic control of BDNF expression has been extensively analyzed in the context of the expression of depression and chronic antidepressant treatments. This evidence concerns the gene BDNF and major depressive disorder.